| Detection of allergic transfusion‐related adverse events from electronic medical records B Whitaker, J Pizarro, M Deady, A Williams, H Ezzeldin, A Belov, ... Transfusion 62 (10), 2029-2038, 2022 | 6 | 2022 |
| The Food and Drug Administration biologics effectiveness and safety initiative facilitates detection of vaccine administrations from unstructured data in medical records … M Deady, H Ezzeldin, K Cook, D Billings, J Pizarro, AA Plotogea, ... Frontiers in Digital Health 3, 777905, 2021 | 6 | 2021 |
| Development of interoperable computable phenotype algorithms for adverse events of special interest to be used for biologics safety surveillance: validation study AA Holdefer, J Pizarro, P Saunders-Hastings, J Beers, A Sang, ... JMIR public health and surveillance 10, e49811, 2024 | 1 | 2024 |
| Innovative Hemovigilance Methods: The FDA CBER Biologics Effectiveness and Safety (BEST) Initiative BI Whitaker, A Williams, G Pappas, AZ Hettinger, A Fong, J Blumenthal, ... 2019 Annual Meeting, 2019 | | 2019 |
